CME
Who Is the Best Candidate for Sequencing Trastuzumab Detruxtecan (T-DXd) First?
July 17, 2023
Host: Erica L. Mayer, MD, MPH
This program explores new evidence that challenges the binary paradigm of HER2+ versus HER2- disease. Evidence is now available that specific antibody-drug conjugates (ADCs) have demonstrated benefit not only in HER
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!